ELDERLY PATIENTS
Clinical trials for ELDERLY PATIENTS explained in plain language.
Never miss a new study
Get alerted when new ELDERLY PATIENTS trials appear
Sign up with your email to follow new studies for ELDERLY PATIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Warm blankets during surgery may shield Seniors' brains
Symptom relief Not yet recruitingThis study tests whether keeping older patients (65+) at a slightly higher body temperature (36.8°C) during major cancer surgery can reduce the risk of delayed neurocognitive recovery—a kind of short-term confusion or memory decline that can happen after surgery. About 1,500 part…
Matched conditions: ELDERLY PATIENTS
Phase: NA • Sponsor: Peking University First Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
New monitoring method may keep seniors breathing easier after surgery
Symptom relief Not yet recruitingThis study looks at whether adding a special carbon dioxide monitor through the nose can reduce dangerous drops in oxygen levels in elderly patients (ages 65-80) waking up from anesthesia after laparoscopic abdominal surgery. About 324 participants will be randomly assigned to st…
Matched conditions: ELDERLY PATIENTS
Phase: NA • Sponsor: Jianbo Wu • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Varicose vein treatment may ease knee pain in seniors
Symptom relief Not yet recruitingThis study looks at whether a common procedure for varicose veins—called endovenous ablation—can also reduce knee pain in people aged 80 and older. The researchers will follow 50 participants for one year after treatment, measuring pain and knee function. The goal is to see if im…
Matched conditions: ELDERLY PATIENTS
Sponsor: Chengdu University of Traditional Chinese Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Could a lower dose of enzalutamide work better for elderly prostate cancer patients?
Knowledge-focused Not yet recruitingThis phase 2 trial is testing four different doses of enzalutamide (40, 80, 120, and 160 mg) in men aged 75 and older with advanced prostate cancer. The goal is to see how drug levels in the blood differ between older and younger patients, and to find the safest and most effectiv…
Matched conditions: ELDERLY PATIENTS
Phase: PHASE2 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC